Dr Vinay Prasad will return to head the FDA’s Center for Biologics Evaluation and Research less than 2 weeks after being ousted.

A well-connected drug company and Laura Loomer wanted Kennedy ally Vinay Prasad gone. Trump chief of staff Susie Wiles got ...

No matter what regulatory decisions Dr. Vinay Prasad makes moving forward, the fact that he was willing to legitimize and ...

Vinay Prasad was reinstated as the head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA) on 11 August. He had resigned on 29 July.1 “At the FDA’s ...

Therapies for rare and deadly disease are dying in Marty Makary’s shop.

Robert F. Kennedy’s right-hand man was briefly Laura Loomer’s latest scalp, but had his job saved thanks to the intervention ...

He’s using Biden-era mistakes to tarnish a promising technology.

DermaRite Industries is recalling certain lots of its over-the-counter soaps, antiseptics, and analgesics due to ...

For more on Prasad’s return, go here; for a “Matt’s Take” on Prasad, go here; for the latest on investors’ attitudes toward ...

A handful of drug companies have formed a group to present lawmakers with research on the negative impacts of Medicare drug ...

Sarepta Therapeutics has provided additional safety data on its gene therapy Elevidys as a Duchenne muscular dystrophy ...

Delays from the Food and Drug Administration continue to pile up, with Maryland-based Regenxbio the latest to report the review of one of its assets ...